Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway.
通过药理学抑制 BMI1 可对 MYCN 扩增的神经母细胞瘤发挥抗肿瘤作用,并激活 p53 通路
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-06922-w
Hirayama Masahiro, Yamada Eri, Aoki Hiromasa, Izumi Kazuya, Amano Ayumi, Toriuchi Kohki, Ogami Koichi, Nagasaka Mai, Inoue Yasumichi, Hayashi Hidetoshi, Takeshita Satoru, Kakita Hiroki, Yamada Yasumasa, Aoyama Mineyoshi